This inventor holds 3 USPTO granted patents and 6 published patent applications and 2 EPO patents. Top assignees: Medimmune Limited, University of California. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 549 
1 out of 16,048 
Years Active: 2023-2026
Title: Ronald James Christie: Innovator in Bioconjugation Methods
Introduction
Ronald James Christie is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of bioconjugation, particularly through his innovative methods and compounds. His work has implications for various applications in biotechnology and pharmaceuticals.
Latest Patents
One of Ronald's key patents is titled "Method and Molecules." This invention provides a bioconjugation method that involves conjugating a biological molecule containing a first unsaturated functional group with a payload that has a second unsaturated functional group. The method utilizes a Diels-Alder reaction to form a cyclohexene ring, showcasing a novel approach to bioconjugation.
Career Highlights
Throughout his career, Ronald has worked with prominent organizations, including MedImmune Limited and the University of California. His experience in these institutions has allowed him to develop and refine his innovative techniques in bioconjugation.
Collaborations
Ronald has collaborated with esteemed colleagues such as Changshou Gao and Andre Henri St Amant. These partnerships have contributed to the advancement of his research and the successful application of his inventions.
Conclusion
In summary, Ronald James Christie is a distinguished inventor whose work in bioconjugation methods has the potential to impact various scientific fields. His innovative approach and collaborations highlight his commitment to advancing biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile